DE60329939D1 - Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit - Google Patents

Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit

Info

Publication number
DE60329939D1
DE60329939D1 DE60329939T DE60329939T DE60329939D1 DE 60329939 D1 DE60329939 D1 DE 60329939D1 DE 60329939 T DE60329939 T DE 60329939T DE 60329939 T DE60329939 T DE 60329939T DE 60329939 D1 DE60329939 D1 DE 60329939D1
Authority
DE
Germany
Prior art keywords
improved biological
formulations
biological compatibility
contrast
mold formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329939T
Other languages
German (de)
English (en)
Inventor
La Jolla Sovak
Allen L Seligson
Ronald C Terry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biophysica Foundation
Original Assignee
Biophysica Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophysica Foundation filed Critical Biophysica Foundation
Application granted granted Critical
Publication of DE60329939D1 publication Critical patent/DE60329939D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60329939T 2002-12-12 2003-11-07 Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit Expired - Lifetime DE60329939D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43287902P 2002-12-12 2002-12-12
US10/701,586 US7250153B2 (en) 2002-12-12 2003-11-05 Contrast media formulations having improved biological tolerance
PCT/US2003/035762 WO2004054637A2 (en) 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance

Publications (1)

Publication Number Publication Date
DE60329939D1 true DE60329939D1 (de) 2009-12-17

Family

ID=34107426

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329939T Expired - Lifetime DE60329939D1 (de) 2002-12-12 2003-11-07 Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit

Country Status (18)

Country Link
US (1) US7250153B2 (https=)
EP (1) EP1575621B1 (https=)
JP (1) JP2006509841A (https=)
KR (1) KR101067159B1 (https=)
CN (1) CN1738651A (https=)
AT (1) ATE447416T1 (https=)
AU (1) AU2003295442B2 (https=)
CA (1) CA2509035C (https=)
CY (1) CY1110105T1 (https=)
DE (1) DE60329939D1 (https=)
DK (1) DK1575621T3 (https=)
ES (1) ES2333863T3 (https=)
IL (1) IL169119A (https=)
NO (1) NO332350B1 (https=)
NZ (1) NZ541139A (https=)
PT (1) PT1575621E (https=)
SI (1) SI1575621T1 (https=)
WO (1) WO2004054637A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1725268B1 (en) * 2004-03-11 2011-10-19 Mallinckrodt LLC X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
US8445725B2 (en) 2008-01-14 2013-05-21 Mallinckrodt Llc Process for the preparation of iosimenol
KR101915821B1 (ko) * 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 x―선 진단용 조성물의 제조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT371998B (de) * 1978-07-04 1983-08-25 Nyegaard & Co As Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
AU6114396A (en) * 1995-06-16 1997-01-15 Biophysica Foundation Formyl derivatives as nonionic contrast media
DE19648650C2 (de) 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung

Also Published As

Publication number Publication date
IL169119A (en) 2010-06-16
EP1575621B1 (en) 2009-11-04
WO2004054637A3 (en) 2004-09-16
ATE447416T1 (de) 2009-11-15
CA2509035C (en) 2011-07-19
NO332350B1 (no) 2012-09-03
US20050025711A1 (en) 2005-02-03
US7250153B2 (en) 2007-07-31
AU2003295442B2 (en) 2008-11-06
KR101067159B1 (ko) 2011-09-22
WO2004054637A2 (en) 2004-07-01
NZ541139A (en) 2008-07-31
DK1575621T3 (da) 2009-12-14
KR20050088312A (ko) 2005-09-05
CY1110105T1 (el) 2015-01-14
ES2333863T3 (es) 2010-03-02
IL169119A0 (en) 2007-07-04
EP1575621A4 (en) 2008-11-26
EP1575621A2 (en) 2005-09-21
AU2003295442A1 (en) 2004-07-09
NO20053343D0 (no) 2005-07-08
SI1575621T1 (sl) 2010-01-29
NO20053343L (no) 2005-09-08
CA2509035A1 (en) 2004-07-01
JP2006509841A (ja) 2006-03-23
PT1575621E (pt) 2009-11-13
CN1738651A (zh) 2006-02-22

Similar Documents

Publication Publication Date Title
BRPI0516463A (pt) cánula escalonada e conjunto de cánula
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
ITMI20031112A1 (it) Un sistema per controllare le relative informazioni d'incontro, per pazienti d'assistenza sanitaria.
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
NO20053150D0 (no) System for administrasjon av medisin.
BRPI0519047A2 (pt) mÉtodo para a produÇço de um agente de contraste marcador ou agente terapÊutico marcador, agentes de contraste marcadores e uso de agentes de contraste marcadores ou de agentes terapÊuticos marcadores
DE60318391D1 (de) Bakteriophagen-lysin
CY1110105T1 (el) Σκευασματα σκιαγραφικων μεσων που εχουν βελτιωμενη ανεκτικοτητα
ITTO20040643A1 (it) Sistema per la gestione di prodotti.
SE0301650D0 (sv) Novel compounds
BRPI0620229A8 (pt) formulação
GT200500308A (es) Nonadepsipeptidos acilados ii
CY1109657T1 (el) Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης
EP1281887A3 (de) Rundlager
PT1713438E (pt) Sabonete medicinal
AR041721A1 (es) Poliamidas
WO2006071949A3 (en) Zebrafish heterotrimer g-protein gamma 2 subunit (gng2)
GT200400022A (es) Nuevas composiciones antihelminticas e insecticidas
TH87788A (th) สูตรยาที่มีการปล่อยคงที่และการใช้ของสิ่งนั้น
GT200300260A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
DE602004012356D1 (de) Pyrrolpolymerzusammensetzungen
GT200300251A (es) Derivados de indolilo
ITRM20030440A0 (it) Sistema d'indicazione temporale, in particolare dell'orario.
TH67349A (th) สารประกอบชนิดใหม่

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIOPHYSICA, INC., LA JOLLA, CALIF., US

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1575621

Country of ref document: EP

Representative=s name: PATENTANWAELTE VON KREISLER, SELTING, WERNER, 5066